Literature DB >> 1606757

Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjögren's syndrome.

D A Sullivan1, E H Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1606757      PMCID： PMC7133161          DOI： 10.1016/0090-1229(92)90052-p

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  81 in total

1.  Tear film physiology.

Authors:  F J Holly
Journal:  Int Ophthalmol Clin       Date:  1987

2.  Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice.

Authors:  R Jonsson; A Tarkowski; K Bäckman; L Klareskog
Journal:  Clin Immunol Immunopathol       Date:  1987-01

3.  Neuroimmunomodulation of in vivo anti-rotavirus humoral immune response.

Authors:  M K Ijaz; D Dent; L A Babiuk
Journal:  J Neuroimmunol       Date:  1990-02       Impact factor: 3.478

4.  Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigation.

Authors:  R Manthorpe; S H Petersen; J U Prause
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-08

5.  Morphology and function of lacrimal gland acinar cells in primary culture.

Authors:  L E Hann; J B Tatro; D A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-01       Impact factor: 4.799

6.  CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.

Authors:  J D Mountz; H R Smith; R L Wilder; J P Reeves; A D Steinberg
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

7.  Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus.

Authors:  C Lavalle; E Loyo; R Paniagua; J A Bermudez; J Herrera; A Graef; D Gonzalez-Barcena; A Fraga
Journal:  J Rheumatol       Date:  1987-04       Impact factor: 4.666

8.  Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.

Authors:  A D Steinberg; J B Roths; E D Murphy; R T Steinberg; E S Raveche
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

9.  Influence of the hypothalamic-pituitary axis on the androgen regulation of the ocular secretory immune system.

Authors:  D A Sullivan
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

10.  Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.

Authors:  W N McKenzie; E V Sunderrajan; J L Kavanaugh; S Braun; L Ansbacher; S E Walker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307
View more
  4 in total

Review 1.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

Review 2.  Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

Authors:  P Oxholm; J U Prause; M Schiødt
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

3.  Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice.

Authors:  R E Hunger; C Carnaud; I Vogt; C Mueller
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Traffic of endogenous, transduced, and endocytosed prolactin in rabbit lacrimal acinar cells.

Authors:  Yanru Wang; Christopher T Chiu; Tamako Nakamura; Ameae M Walker; Barbara Petridou; Melvin D Trousdale; Sarah F Hamm-Alvarez; Austin K Mircheff; Joel E Schechter
Journal:  Exp Eye Res       Date:  2007-08-24       Impact factor: 3.467
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.